Introduction
The retroviral oncogene v-jun of avian sarcoma virus 17 is derived from the cellular jun (c-jun) gene which codes for a bZip protein component of the AP-1 transcription factor complex (Bohmann et al., 1987; Maki et al., 1987; Angel et al., 1988; Lamph et al., 1988; Nishimura and Vogt, 1988) . Expression of v-jun in chicken embryo fibroblasts (CEF) and in the murine fibroblast line C3H 10T1/2 cells (10T1/2 cells) leads to oncogenic transformation (Cavalieri et al., 1985; Maki et al., 1987; Cohen et al., 2001) . Identification of target genes with altered expression levels in cells transformed by the v-Jun protein is a prerequisite to understanding the mechanism of transformation. Differentially expressed genes need to be validated as transformation-relevant targets by functional tests. Since the number of differentially expressed genes in v-Jun-transformed cells is large, it is necessary to develop methods that filter relevant targets from innocuous bystanders. DNA microarray analyses were performed to find genes with altered expression levels in v-Jun transformed 10T1/2 cells (Cohen et al., 2001) . Each EST and cDNA sequence on the array was used to extract gene identity information from the UniGene database using GeneHuggers (Cohen et al., 2001; Wheeler et al., 2002; Iacovoni, 2003) . Genes induced or repressed by at least 2.5-fold are shown in Tables 1 and 2, respectively. We were particularly interested in downregulated genes, because their relevance for oncogenic transformation can be readily tested by re-expressing them in transformed cells. If downregulation of the gene in question is essential for oncogenic transformation, such re-expression should cause at least a partial reversion of the transformed phenotype. In previous work, we have shown that the protein Akap12 (A-kinase anchoring protein), also known as SSeCKs (Src suppressed protein kinase C substrate) or Gravin, is downregulated at the transcriptional level in Jun-transformed 10T1/2 cells and that re-expression of this target induces reversion of transformation (Cohen et al., 2001) . Akap12 is repressed in NIH3T3 cells transformed by the Src, Ras, Fos, or Myc oncoproteins and is capable of reverting the Srcinduced phenotype Lin et al., 1995 Lin et al., , 1996 Gelman, 2002) . In the present communication, we extend our observations on Akap12 and report on a second protein downregulated at the transcriptional level in Jun-transformed 10T1/2 cells, Marcks (myristoylated alanine-rich C kinase substrate). Like Akap12, Marcks is capable of reverting the Juntransformed phenotype, as determined by agar colony and growth rate assays (Cohen, 2001 ; data not shown). Marcks is also downregulated in Src-and Ras-transformed murine fibroblasts and is relocated in transformed cells from the cell periphery to the cytosol (Reed et al., 1991; Joseph et al., 1992) . We have used the v-Jun expressing 10T1/2 cells reverted by Akap12 or Marcks as indicators for the behavior of other target genes, arguing that correlation of expression levels with cellular phenotype suggests a role in the determination of that phenotype. Genes that are upregulated in transformed cells but expressed at control levels in revertants and, vice versa, genes downregulated in transformed cells and re-expressed in revertants are likely to be related to the transformation process. In contrast, genes differentially expressed in Jun-transformed cells but failing to adjust their expression in revertants are probably unrelated to the transformation process.
We have generated six stably transfected sublines of 10T1/2 cells expressing v-Jun, v-Jun and Akap12, v-Jun and Marcks, empty vector, Akap12 or Marcks respectively (Figure 1 ). v-Jun expressing cells show transformed morphology and are capable of anchorage-independent growth. When Akap12 or Marcks is re-expressed in these cells, they acquire a flattened shape and expanded adherence to the substrate, similar to control 10T1/2 cells transfected with empty vector alone. These Akap12-or Marcks-induced revertants of v-Juntransformed cells have also lost the ability to form colonies in nutrient agar and show reduced growth rates as compared to their transformed progenitors (Cohen, 2001; data mRNA from v-Jun-transformed 10T1/2 murine cells and from their normal 10T1/2 progenitors was used to identify differentially regulated genes in a commercial microarray (Incyte Pharmaceuticals). Known internal controls were run with the experimental samples and were used to normalize the results. Changes of 1.7-fold and above were found to be statistically significant. Tables 1 and 2 use a 2.5-fold change as the cut off Akap12 is toxic to 10T1/2 cells. We found that some selected clones became growth-arrested and that by passaging Akap12 expressing cells, we may have selected lines that produce low levels of exogenous Akap12. The expression of Marcks and Akap12 is therefore coupled, and it is correlated with the cellular phenotype, down in transformed cells, and restored in revertants.
The small proline-rich protein 1A (Sprr1a) represents an additional Jun target with an expression pattern that correlates with transformation (Figure 3) . DNA microarrays show this gene to be induced 10.5-fold in Juntransformed cells. It encodes a small proline-rich protein, originally identified as having a cross-bridging function in the formation of cornified cell envelopes of stratified squamous epithelia (Kartasova et al., 1996) . Recently, this gene has been shown to be TPA-inducible and to be expressed at high basal levels in advanced stages of skin cancer (Schlingemann et al., 2003) . The fact that v-Jun-induced transcriptional upregulation of Sprr1a is lost in reverted cells suggests that this gene may play a role in transformation, but additional Figure 3 Expression profiles of four selected v-Jun targets determined by Northern blotting. Total RNA preparation and Northern blotting were performed as previously described (Fu et al., 1999) . In total, 25 mg of total RNA were prepared using RNA Stat (Tel-Test (Friendswood, TX, USA)) from each of the six cell lines: J, JM, JA, M, A, and C. RNA samples were separated on 1% denaturing agarose gels and transferred on to nitrocellulose membranes (Amersham). Equal loading of each sample was confirmed by ethidium bromide staining of ribosomal RNA. Individual primer pairs were designed to amplify 800-1000 base pair regions of publicly available mouse mRNA sequences using Primer 2.0 software. PCR was performed on a first strand cDNA preparation made from a mixture of v-Jun-transformed and control 10T1/2 RNA. PCR products were gel-purified and 32 P labeled with a random primed labeling kit (Roche). Hybridization, washing and detection were performed as described previously (Fu et al., 1999) . Images were obtained with ImageQuant software and the Storm Phosphorimager (Molecular Dynamics) Primers were designed to amplify fragments of mouse and chicken jun. Due to the deletion of the delta region in v-Jun, this PCR amplification generates different sized products for c-Jun and vJun. In total, 20 cycles of RT-PCR were carried out with 1 mg total RNA as described by the manufacturer (GibcoBRL, SuperScript One-Step RT-PCR with Platinum Taq). Products were resolved on a 10% polyacrylamide gel and stained with ethidium bromide. (b) Marcks and (c) Akap12 expression were determined by Western blotting of 15 mg total protein from whole-cell lysates as previously described (Cohen et al., 2001) . Marcks was detected with a commercial antibody sc-6455 (Santa Cruz) and Akap12 with gravin antiserum obtained from MH Ginsberg (Grove et al., 1994) . functional studies will be required to confirm this proposal.
The galactose-binding, soluble lectin 3 (Lgals3) (Figure 3) , was found by DNA microarrays to be upregulated in Jun-transformed cells. The upregulation was confirmed by Northern blotting, yet this upregulation was not changed by Marcks-or Akap12-induced reversion. Lgals3 expression was even enhanced in cells singly expressing either tumor suppressor.
Two downregulated targets, serine protease inhibitor, clade E, member 2 (Serpine2), and osteoblast-specific factor 2 (Osf2) were also examined. Osf2 is also downregulated by Jun in avian cells (Hartl et al., 2003) . Serpine2 was found in DNA microarrays to be downregulated 13.7-fold. However, neither of these targets have an expression pattern that correlates with transformation; rather, they show a v-Jun-dependent downregulation. All three cell lines expressing v-Jun, regardless of revertant status, show a reduction in Osf2 and Serpine2 expression. In cells expressing Akap12 singly, Osf2 levels are unaltered, but those of Serpine 2 are reduced. Cells expressing Marcks alone show reduction of Osf2 levels while those of Serpine 2 are unchanged.
The downregulation of Akap12 and of Marcks is an essential requirement for Jun-induced transformation. Akap12-or Marcks-induced revertants of v-Jun-transformed 10T1/2 cells, together with transformed and control cells, can be used to classify Jun targets into three categories: (1) Targets with expression levels that are correlated with the cellular phenotype. These include Akap12, Marcks, c-Jun and Sprr1a. (2) Targets whose expression is correlated with that of v-Jun but not with the cellular phenotype. Examples are Osf2 and Serpine2. (3) Targets that follow neither cellular phenotype nor v-Jun in their expression levels. One such example is Lgals3. Category (1) is likely to contain targets that are relevant for transformation, because reversion of the transformed phenotype also cancels the differential expression induced by the oncoprotein without changing levels of the oncoprotein itself. However, the three categories of targets are correlative and can only suggest relevance or irrelevance for transformation. Category (1) could contain irrelevant targets and category (2) relevant ones, necessary but not sufficient for transformation. The unabated expression of v-Jun in Akap12-and Marcks-reverted cells is of special significance. It implies cancellation of the transforming activities of v-Jun. In the case of category (1) targets, this cancellation occurs at the level of transcriptional regulation; in the revertants v-Jun is prevented from regulating its target promoters. These findings suggest that analyses of all six cell lines with DNA microarrays should identify all genes that posses correlative transcriptional expression patterns. In conclusion, our observations offer a new method for sifting through and identifying transformation-relevant v-Jun targets. The data also raise interesting questions on the control of v-Jun in revertant cells.
